| |
| |
|
| Insider
Information: |
Morosini Deborah |
| Relationship: |
EVP, Chief of Clinical... |
| City: |
Wilmington |
| State: |
DE |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
444 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
444 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Prelude Therapeutics Inc |
PRLD |
EVP, Chief of Clinical... |
2021-12-15 |
444 |
2020-09-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2021-12-15 |
4 |
AS |
$13.00 |
$373,763 |
D/D |
(28,751) |
444 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2021-12-15 |
4 |
OE |
$1.89 |
$336,395 |
D/D |
28,751 |
29,195 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2021-11-16 |
4 |
AS |
$15.87 |
$456,532 |
D/D |
(28,751) |
444 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2021-11-16 |
4 |
OE |
$12.85 |
$369,450 |
D/D |
28,751 |
29,195 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2021-04-29 |
4 |
AS |
$40.29 |
$129,853 |
D/D |
(3,223) |
444 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2021-04-29 |
4 |
OE |
$1.89 |
$6,091 |
D/D |
3,223 |
3,667 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2021-04-08 |
4 |
AS |
$40.00 |
$4,000 |
D/D |
(100) |
444 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2021-04-08 |
4 |
OE |
$1.89 |
$189 |
D/D |
100 |
544 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2021-04-07 |
4 |
AS |
$40.04 |
$40,043 |
D/D |
(1,000) |
444 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2021-04-07 |
4 |
OE |
$1.89 |
$1,890 |
D/D |
1,000 |
1,444 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
EVP, Chief of Clinical Affairs |
• – – |
2020-09-29 |
4 |
B |
$19.00 |
$8,436 |
D/D |
444 |
444 |
2.74 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
